James Campbell
Internal Medicine · Pasco, WANPI 1902820277
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.9% of the total across 135 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 23 manufacturers, the largest accounting for just 22.5% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $951 and has fallen 67.0% since, to $314 in 2022. Among internal medicine clinicians in WA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 135 payments — averaging $17.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$543
- Novo Nordisk$336
- Pfizer$224
- AbbVie$180
- Boehringer Ingelheim$127
- Merck$115
- plus $888 from 17 others
What the payments were for
- Speaking & faculty fees$221%
- Food & beverage$2,33897%
- Education$542%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 27 | $543 |
| Novo Nordisk | 24 | $336 |
| Pfizer | 7 | $224 |
| AbbVie(2 entities) | 10 | $180 |
| Boehringer Ingelheim | 6 | $127 |
| Merck | 9 | $115 |
| Amgen(2 entities) | 6 | $106 |
| GSK | 4 | $97 |
| Mylan Specialty L.p. | 5 | $91 |
| Novartis | 6 | $90 |
| Esperion Therapeutics, Inc. | 5 | $82 |
| Biogen | 4 | $81 |
| Lilly USA, LLC | 5 | $74 |
| Eisai Inc. | 3 | $42 |
| Johnson & Johnson | 2 | $36 |
| Bayer | 2 | $33 |
| Sanofi-aventis U.S. LLC | 2 | $32 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $27 |
| Abbott | 1 | $24 |
| Astellas Pharma US Inc | 2 | $23 |
| Kowa Pharmaceuticals America, Inc. | 1 | $18 |
| E.r. Squibb & Sons, L.L.C. | 1 | $18 |
| Phadia US Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- COLOGUARD$125
How this compares
$2,414 in reported general payments places this provider in the 90th percentile of 2,038 internal medicine providers in Washington.
Other internal medicine in Pasco
- Alex NajeraPasco$6K
- Peter ShalitSeattle$1M
- Lawrence LoebBellevue$784K
- Shawna PurcellOlympia$294K
- Scott RamseySeattle$230K
- Michael CairnsSeattle$144K
- Peiqing QianSeattle$117K
- Alan KellySpokane Valley$96K
- Emily EgdaminWenatchee$81K
- Royce MorrisonTacoma$72K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.